"SPD politicians are challenging the GKV contribution stabilization law proposed by Health Minister Nina Warken. Concerns are raised regarding the impact of austerity measures on pharmaceutical investment and research. The coalition is divided over the balance between fiscal stability and industrial competitiveness."